Chimerix Inc (CMRX)
0.9586
+0.01
(+0.87%)
USD |
NASDAQ |
Oct 04, 12:57
Chimerix Price: 0.9586 for Oct. 4, 2023
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Oct 03, 2023 | 0.955 | 0.9646 | 0.9307 | 0.9503 | 427065.0 |
Oct 02, 2023 | 0.96 | 0.9799 | 0.96 | 0.9729 | 334156.0 |
Sep 29, 2023 | 0.97 | 0.99 | 0.95 | 0.9598 | 594752.0 |
Sep 28, 2023 | 1.01 | 1.02 | 0.9601 | 0.97 | 1.474M |
Sep 27, 2023 | 1.01 | 1.03 | 0.99 | 1.01 | 356234.0 |
Sep 26, 2023 | 0.97 | 1.01 | 0.9502 | 0.9835 | 564235.0 |
Sep 25, 2023 | 1.06 | 1.07 | 0.95 | 0.98 | 1.178M |
Sep 22, 2023 | 1.05 | 1.05 | 1.02 | 1.04 | 218605.0 |
Sep 21, 2023 | 1.04 | 1.078 | 1.02 | 1.045 | 223033.0 |
Sep 20, 2023 | 1.05 | 1.07 | 1.05 | 1.055 | 427586.0 |
Sep 19, 2023 | 1.05 | 1.07 | 1.03 | 1.06 | 452046.0 |
Sep 18, 2023 | 1.05 | 1.05 | 1.02 | 1.03 | 290295.0 |
Sep 15, 2023 | 1.04 | 1.08 | 1.04 | 1.04 | 687996.0 |
Sep 14, 2023 | 1.05 | 1.075 | 1.045 | 1.06 | 414988.0 |
Sep 13, 2023 | 1.11 | 1.11 | 1.06 | 1.06 | 1.027M |
Sep 12, 2023 | 1.06 | 1.12 | 1.04 | 1.095 | 625793.0 |
Sep 11, 2023 | 1.06 | 1.08 | 1.02 | 1.06 | 731874.0 |
Sep 08, 2023 | 1.05 | 1.07 | 1.04 | 1.06 | 260890.0 |
Sep 07, 2023 | 1.04 | 1.065 | 1.02 | 1.05 | 671505.0 |
Sep 06, 2023 | 1.11 | 1.11 | 1.04 | 1.07 | 404870.0 |
Sep 05, 2023 | 1.08 | 1.10 | 1.07 | 1.10 | 283700.0 |
Sep 01, 2023 | 1.14 | 1.15 | 1.03 | 1.075 | 673955.0 |
Aug 31, 2023 | 1.12 | 1.165 | 1.11 | 1.14 | 691430.0 |
Aug 30, 2023 | 1.11 | 1.12 | 1.09 | 1.11 | 327523.0 |
Aug 29, 2023 | 1.07 | 1.11 | 1.06 | 1.10 | 580697.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.9429
Minimum
Aug 18 2023
11.25
Maximum
Feb 17 2021
3.576
Average
2.70
Median
Jan 18 2019
Price Benchmarks
Alnylam Pharmaceuticals Inc | 169.24 |
Regeneron Pharmaceuticals Inc | 813.05 |
Innoviva Inc | 13.09 |
Arbutus Biopharma Corp | 1.885 |
Agios Pharmaceuticals Inc | 24.04 |
Price Related Metrics
PE Ratio | 0.4653 |
PS Ratio | 2.510 |
Price to Book Value | 0.3789 |
Earnings Yield | 214.9% |
Market Cap | 84.92M |